If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

Share Price is delayed by 15 minutes
Get Live Data
2,290.00    -22.00 (-0.95%)
Bid:
2,288.00
Ask:
2,292.00
Spread: 4.00 (0.175%)
Market Cap: £1.52b
GNS Live PriceLast checked at - London Stock Exchange

Intraday Genus Share Chart

Director/PDMR Shareholding

8 Dec 2017 16:41

RNS Number : 8772Y
Genus PLC
08 December 2017
Β 

8 December 2017

Β 

Genus plc

Β 

Director/PDMR Shareholding

Β 

Genus plc (LSE: GNS) announces that, further to the vesting of conditional shares on 20 November 2017 under the Genus 2014 Performance Share Plan ('PSP') as listed in table A below, a member of the Genus Executive Leadership Team ('GELT') sold ordinary shares in Genus on 22 November 2017 on the London Stock Exchange to partly offset income tax and social security liabilities due on the exercise. This exercise and sale was inadvertently not included in the announcement made on 23 November 2017.

Β 

The below notification, made in accordance with the requirements of the EU Market Abuse Regulation, give further detail of the number of conditional shares exercised and ordinary shares sold on 22 November 2017.

Β 

For further information please contact:

Β 

Genus:

Cara Crichton, Deputy Company Secretary Tel: +44 (0)1256 347100

Β 

Β 

Table A - GELT 2014 Performance Share Plan Exercise

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Angelle Rosata

2.

Reason for the notification

a.

Position/status

Group Human Resources Director

Β 

b.

Initial notification

/Amendment

Β 

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Genus plc

b.

LEI

54930022EOITNKSIGH56

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

Β 

Β 

GB0002074580

b.

Nature of the transaction

Exercise of 829 conditional shares under the PSP.

Β 

c.

Price(s) and volume(s)

Β 

Price(s)

Β 

Volume(s)

0p

829

Β 

d.

Aggregated information

Β· Aggregated volume

Β· Price

Β 

Β 

Average price(s)

Β 

Total volume(s)

0p

829

e.

Date of the transaction

2017-11-22

f.

Place of the transaction

Outside a trading venue.

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Β 

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

Β 

Β 

GB0002074580

b.

Nature of the transaction

Sale of 829 shares arising from the exercise of conditional shares under the PSP partly to offset income tax and social security liabilities due on the exercise.

c.

Price(s) and volume(s)

Β 

Price(s)

Β 

Volume(s)

2,185.42p

829

d.

Aggregated information

Β· Aggregated volume

Β· Price

Β 

Β 

Aggregated price(s)

Β 

Total volume(s)

2,185.42p

829

e.

Date of the transaction

2017-11-22

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
DSHUWONRBKAURAA
Date   Source Headline
31st Jul 20122:00 pmRNSBlocklisting Interim Review
31st Jul 20122:00 pmRNSTotal Voting Rights
31st Jul 20127:00 amRNSJoint Venture in China
4th Jul 20127:00 amRNSPre-Close Trading Statement
15th May 20124:09 pmRNSHolding(s) in Company
15th May 20124:08 pmRNSHolding(s) in Company
3rd May 20127:00 amRNSInterim Management Statement and Strategy Update
30th Apr 20122:00 pmRNSTotal Voting Rights
30th Mar 20122:00 pmRNSTotal Voting Rights
14th Mar 20122:00 pmRNSDirector/PDMR Shareholding
29th Feb 20122:00 pmRNSTotal Voting Rights
27th Feb 20124:25 pmRNSHolding(s) in Company
21st Feb 20123:16 pmRNSHolding(s) in Company
21st Feb 20122:30 pmRNSDirector/PDMR Shareholding
21st Feb 20127:00 amRNSInterim Results
31st Jan 20122:00 pmRNSBlocklisting Interim Review
31st Jan 201210:44 amRNSNotice of Results
16th Jan 20123:49 pmRNSHolding(s) in Company
4th Jan 20127:00 amRNSSenior Management Changes
30th Dec 201112:00 pmRNSTotal Voting Rights
30th Nov 20112:00 pmRNSTotal Voting Rights
10th Nov 201112:51 pmRNSResult of AGM
10th Nov 20117:00 amRNSAGM and Interim Management Statement
31st Oct 20112:00 pmRNSTotal Voting Rights
27th Oct 20112:00 pmRNSAnnual Information Update
11th Oct 201111:39 amRNSAnnual Report and Annual General Meeting
30th Sep 20112:44 pmRNSTotal Voting Rights
22nd Sep 20112:33 pmRNSHolding(s) in Company
20th Sep 20113:08 pmRNSAdditional Listing
20th Sep 20113:07 pmRNSDirector/PDMR Shareholding
9th Sep 201111:00 amRNSDirector/PDMR Shareholding
6th Sep 20117:00 amRNSPreliminary Results
31st Aug 20112:00 pmRNSTotal Voting Rights
29th Jul 20112:00 pmRNSBlocklisting Interim Review
29th Jul 20112:00 pmRNSTotal Voting Rights
4th Jul 20117:00 amRNSPre-close Trading Statement
25th May 20117:00 amRNSCEO Retirement and Appointment of Successor
12th May 20112:08 pmRNSHolding(s) in Company
11th May 20117:00 amRNSInterim Management Statement
28th Apr 20112:00 pmRNSTotal Voting Rights
31st Mar 20112:00 pmRNSTotal Voting Rights
10th Mar 20115:56 pmRNSHolding(s) in Company
9th Mar 201111:00 amRNSDirector Shareholding
28th Feb 20112:37 pmRNSTotal Voting Rights
22nd Feb 20117:00 amRNSInterim Results
31st Jan 20112:00 pmRNSBlocklisting Interim Review
31st Jan 20112:00 pmRNSTotal Voting Rights
27th Jan 20113:57 pmRNSNotice of Results
21st Jan 20113:36 pmRNSHolding(s) in Company
30th Nov 20102:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.